Characteristics associated between the incidence of hip osteoarthritis and early hip complaints (CHECK study) within 10 years

Associations between biomarkers of matrix metabolism and inflammation with pain and fatigue in participants suspected of early hip and or knee osteoarthritis: data from the CHECK study

OBJECTIVES

To assess the associations of biomarkers in serum [highsensitivity C-reactive protein (hs-CRP), serum cartilage oligomeric protein (sCOMP), serum propeptide of type I procollagen (sPINP) and serum osteocalcin (sOC)] and urine [urinary type II collagen telopeptide (uCTX-2)] with the extent and progression of nocturnal pain, pain while walking, and fatigue in participants with hip and/or knee pain suspected to be early stage osteoarthritis (OA).

METHODS

hs-CRP, uCTX-2, sCOMP, sPINP and sOC were measured at baseline in 1,002 participants of the Cohort Hip and Cohort Knee (CHECK). Nocturnal pain, pain while walking and fatigue were assessed by self-reported questionnaires at baseline and 2-year follow-up. Associations between these biomarkers and symptoms were examined using logistic and linear regression analyses.

RESULTS

hs-CRP was significantly associated with mild nocturnal pain (OR 1.18 95% CI 1.01-1.37), with mild and moderate pain while walking (OR 1.17 95% CI 1.01-1.35 and OR 1.56 95% CI 1.29-1.90, respectively) and with progression of nocturnal pain (OR 1.25 95% CI 1.07-1.46). uCTX-2 was associated with mild nocturnal pain (OR 1.40 95% CI 1.05-1.85) and with mild and severe-extreme pain while walking (OR 1.35 95% CI 1.04-1.75 and OR 2.55 95% CI 1.03-6.34, respectively). sPINP was associated with severe-extreme nocturnal pain (OR 0.45 95% CI 0.25-0.82). No significant associations were found for sCOMP and sOC, nor for any of the biomarkers and fatigue.

CONCLUSION

This study of biomarkers in a large cohort of participants with hip and/or knee pain suspected to reflect early stage hip and/or knee OA suggests that inflammation and cartilage matrix degeneration play a role in pain, but not in fatigue.

Correlation of femoral version measurements between computed tomography and magnetic resonance imaging studies in patients presenting with a femoroacetabular impingement-related complaint

Computed tomography (CT) is considered the gold standard for femoral version measurement. However, recent data have shown magnetic resonance imaging (MRI) as another modality to measure femoral version. This study aimed to correlate MRI and CT femoral version measurements in patients presenting with a femoroacetabular impingement (FAI)-related complaint. Patients (18-35 years old) who presented to the hip preservation clinic and radiology department with a suspected FAI diagnosis from 26 December 2018 to 4 March 2020 were included. All patients had a CT and MRI of the hip, with images including both hips and knees, as per our institution's protocol for possible hip preservation surgery. Patients were excluded if they were missing views of the knees, or if they had a history or imaging appearance of any condition affecting femoral version at the femoral head (e.g. slipped capital femoral epiphysis). Femoral version was measured by three reviewers. Fifty-eight patients were included, and 36 (62%) were female. Femoral version averaged 6.1° ± 11.8° on CT and 6.5° ± 10.8° on MRI. A strong positive correlation was reported between the two imaging modalities (r: 0.81; P < 0.001). Inter-rater reliability among the three reviewers was excellent and statistically significant for measurements on both MRI [intraclass correlation coefficient (ICC): 0.95; 95% CI: 0.85, 0.99; P < 0.001] and CT (ICC: 0.97; 95% CI: 0.92, 0.99; P < 0.001). Our finding suggests that MRI is a sufficient method for measuring femoral version to determine disease etiology and treatment progression. To avoid exposing patients to ionizing radiation, physicians should not obtain CT scans to evaluate femoral version.